Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza
- PMID: 6740094
- DOI: 10.1093/clinids/6.supplement_2.s467
Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza
Abstract
Trivalent oral poliovirus vaccine ( TOPV ) has been used in Gaza since 1967. After an initial decrease of 33% in the incidence of the paralytic disease, no further decrease could be noted. The mean annual incidence until 1977 was 10 per 100,000 inhabitants. Two outbreaks caused by poliovirus type 1 were registered in 1974 and 1976 with an incidence of 18 per 100,000 inhabitants. In these outbreaks, 34% and 50% of the affected children, respectively, had received three to four doses of TOPV . A new vaccination schedule was introduced in 1978, combining live and inactivated poliovirus vaccines. In the years 1978-1980, the incidence decreased to 2.6 per 100,000 inhabitants; and during 1981-1982, only three cases were recorded. These results indicate that a schedule like the one used in Gaza could serve as a model to control poliomyelitis in developing countries where TOPV alone is not successful.
Similar articles
-
Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.Dev Biol Stand. 1986;65:137-43. Dev Biol Stand. 1986. PMID: 3556771
-
Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark.Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S471-4. doi: 10.1093/clinids/6.supplement_2.s471. Rev Infect Dis. 1984. PMID: 6740095
-
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26. Lancet Infect Dis. 2015. PMID: 26318714 Clinical Trial.
-
Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States.Pediatr Infect Dis J. 1987 Oct;6(10):881-7. doi: 10.1097/00006454-198710000-00001. Pediatr Infect Dis J. 1987. PMID: 3320922 Review.
-
Vaccinology of poliomyelitis.Vaccine. 1984 Mar;2(1):59-74. doi: 10.1016/s0264-410x(98)90035-4. Vaccine. 1984. PMID: 6099644 Review.
Cited by
-
The final stages of the global eradication of poliomyelitis.Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120140. doi: 10.1098/rstb.2012.0140. Print 2013 Aug 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23798688 Free PMC article. Review.
-
Future of polio vaccines.Expert Rev Vaccines. 2009 Jul;8(7):899-905. doi: 10.1586/erv.09.49. Expert Rev Vaccines. 2009. PMID: 19545205 Free PMC article. Review.
-
Controversies in polio immunization.Indian J Pediatr. 2003 Jul;70(7):567-71. doi: 10.1007/BF02723160. Indian J Pediatr. 2003. PMID: 12940379
-
Current status of poliovirus infections.Clin Microbiol Rev. 1996 Jul;9(3):293-300. doi: 10.1128/CMR.9.3.293. Clin Microbiol Rev. 1996. PMID: 8809461 Free PMC article. Review.
-
Clinical efficacy of trivalent oral poliomyelitis vaccine: a case-control study.Bull World Health Organ. 1993;71(3-4):307-9. Bull World Health Organ. 1993. PMID: 8324848 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical